Biomarker Lens

Biomarkers · Chemical

Mitragynine

What it measures

Tests in the graph that measure it
4

A plain-language description with its source has not been added for this biomarker yet. What the laboratories say about the tests that measure it is below.

Tests that measure Mitragynine

Drug Monitoring Opioids Panel with Confirmation Urine

Laboratory
Quest Diagnostics
Test code
39013
Specimen
Urine
Fasting
Not stated as required

What the laboratory says this test is for

Monitoring of parent compounds and their metabolites in urine. The results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.

Quest Diagnostics test directory, test code 39013

Drug Monitoring Opioids Panel Quantitative Urine

Laboratory
Quest Diagnostics
Test code
39012
Specimen
Urine
Fasting
Not stated as required

What the laboratory says this test is for

Monitoring of parent compounds and their metabolites in urine. The results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.

Quest Diagnostics test directory, test code 39012

Comprehensive Drug Screen Umbilical Cord Tissue

Laboratory
Quest Diagnostics
Test code
94488
Specimen
10 g umbilical cord
Fasting
Not stated as required

What the laboratory says this test is for

Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology.

Quest Diagnostics test directory, test code 94488

Drug Monitoring Assess Panel Extended Quantitative Urine

Laboratory
Quest Diagnostics
Test code
39992
Specimen
Urine
Fasting
Not stated as required

What the laboratory says this test is for

A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites across drug classes facilitates enhanced patient care. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Quest Diagnostics test directory, test code 39992

About this page

Everything above is drawn from the named sources and shown as they published it. Reference ranges belong to the laboratory that issued them and the population it named; they are not a universal normal. This page describes the biomarker in general and does not interpret anyone's result. For your own numbers, talk to a clinician, or use Aumnivida, which reads the same graph next to your records.

Found an error? Write to hello@biomarkerlens.com with the page link and the source that contradicts it.